Company Registration No. 11915403 (England and Wales)
RE-GEN CLINIC LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
RE-GEN CLINIC LIMITED
BALANCE SHEET
AS AT
31 MARCH 2023
31 March 2023
- 1 -
2023
2022
Notes
£
£
£
£
Current assets
Debtors
(1)
-
0
Cash at bank and in hand
449
40
448
40
Creditors: amounts falling due within one year
(3,928)
(1,200)
Net current liabilities
(3,480)
(1,160)
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss reserves
(4,480)
(2,160)
Total equity
(3,480)
(1,160)

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 13 October 2023
Dr Christopher Lalemi
Director
Company Registration No. 11915403
RE-GEN CLINIC LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2023
31 March 2023
- 2 -
1
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
1
1
2023-03-312022-04-01false13 October 2023CCH SoftwareCCH Accounts Production 2023.300No description of principal activityDr Christopher Lalemifalse11915403119154032022-04-012023-03-31119154032023-03-31119154032022-03-3111915403core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3111915403core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3111915403core:ShareCapital2023-03-3111915403core:ShareCapital2022-03-3111915403core:RetainedEarningsAccumulatedLosses2023-03-3111915403core:RetainedEarningsAccumulatedLosses2022-03-3111915403bus:Director12022-04-012023-03-31119154032021-04-012022-03-3111915403bus:PrivateLimitedCompanyLtd2022-04-012023-03-3111915403bus:SmallCompaniesRegimeForAccounts2022-04-012023-03-3111915403bus:FRS1022022-04-012023-03-3111915403bus:AuditExemptWithAccountantsReport2022-04-012023-03-3111915403bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP